The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2019

Filed:

Aug. 12, 2015
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Irina M. Conboy, El Sobrante, CA (US);

David Vernon Schaffer, Danville, CA (US);

Hanadie Yousef, San Mateo, CA (US);

Michael J. Conboy, El Sobrante, CA (US);

Wendy Cousin, Berkeley, CA (US);

Christian Elabd, Berkeley, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/11 (2006.01); A61K 38/18 (2006.01); A61K 31/444 (2006.01); A61K 31/536 (2006.01); C12N 5/077 (2010.01); C12N 5/0797 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 38/11 (2013.01); A61K 31/444 (2013.01); A61K 31/536 (2013.01); A61K 38/1841 (2013.01); C12N 5/0623 (2013.01); C12N 5/0658 (2013.01); G01N 33/502 (2013.01); C12N 2501/30 (2013.01); C12N 2501/727 (2013.01); C12N 2501/999 (2013.01);
Abstract

Methods, pharmaceutical compositions, and kits are provided for treating a subject with an effective amount of an oxytocin receptor (OXTR) agonist and an effective amount of an ALK5 antagonist. In certain aspects, the OXTR agonist may be oxytocin or an oxytocin analog (e.g., a small molecule). The ALK 5 antagonist may be a small molecule, such as 2-(3-(6-Methyl-pyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine, LY2157299, A 83-01, D 4476, GW 788388, LY 364947, Rep Sox, SB 431542, SB 505124, SB 525334, or SD 208. In certain aspects, the amounts of the OXTR agonist and ALK5 antagonist may be sufficient to induce muscle regeneration and/or neural cell regeneration in the subject.


Find Patent Forward Citations

Loading…